JCHOR
Journal of Current Hematology & Oncology Research

The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

eISSN: 2980-0854
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Original Article
Gastric cancer patient characteristics in a city in the Central Anatolian Region of Turkey: A single-center descriptive study
Abstract
Aims: This study aimed to determine the characteristics of patients with gastric cancer living in Eskişehir, a city located in the central Anatolian region of Turkey, together with factors affecting the recurrence and survival time.
Methods: This descriptive cross-sectional study was conducted using patients records who were admitted to Eskişehir Osmangazi University Health Practice and Research Hospital, Department of Internal Medicine between December 1998 and January 2011 with a diagnosis of gastric cancer. Missing data was obtained by calling the patients or their relatives by phone.
Results: We evaluated 210 gastric cancer patients in this study.Male sex was approximately 2.5 times dominant, and most of the patients were diagnosed between the ages of 60-69. Approximately 1/5th of the patients applied to the health center 6 months after the onset of symptoms. Age, chemotherapy, and radiotherapy were significantly related to recurrence (p=0.028, p=0.009, and p=0.005, respectively). Stage, area of involvement, positive surgical margin, chemotherapy, radiotherapy, and the number of lymph nodes removed were significantly related to survival time (p<0.001 for all variables).
Conclusion: In the studied population, gastric cancer diagnosis is delayed in a significant proportion of symptomatic patients. To decrease missed diagnoses, health professionals, especially those working in primary health care, should be made more sensitive towards the red flags of gastric cancer. Chemotherapy and radiotherapy are effective treatment options in preventing recurrences and improving survival.

Keywords : Gastric cancer, diagnosis, survival, recurrence, chemotherapy, radiotherapy

Download Article


1. Thrift AP, El-Serag HB. Burden of gastric cancer. Clin GastroenterolHepatol. 2020;18(3):534-542. doi:10.1016/j.cgh.2019.07.045
2. Waldum H, Fossmark R. Gastritis, gastric polyps and gastric cancer. IntJ Mol Sci. 2021;22(12):6548. doi:10.3390/ijms22126548
3. Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, riskfactors and prevention. Prz Gastroenterol. 2019;14(1):26-38. doi:10.5114/pg.2018.80001
4. Organization WH. Estimated Age-Standardized Incidence Rates(World) in 2020. All cancers. Both Sexes. All Ages. 2020.
5. Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F.Gastric cancer: descriptive epidemiology, risk factors, screening, andprevention. Cancer Epidemiol Biomarkers Prev. 2014;23(5):700-713.doi:10.1158/1055-9965.EPI-13-1057
6. Yusefi AR, Bagheri Lankarani K, Bastani P, Radinmanesh M, Kavosi Z.Risk factors for gastric cancer: a systematic review. Asian Pac J CancerPrev. 2018;19(3):591-603. doi:10.22034/APJCP.2018.19.3.591
7. Ajani JA, D&rsquo;Amico TA, Almhanna K, et al. Gastric cancer, version3.2016, NCCN clinical practice guidelines in oncology. J Natl ComprCanc Netw. 2016;14(10):1286-1312. doi:10.6004/jnccn.2016.0137
8. Ajani JA, Lee J, Sano T, Janjigian YY, Fan D, Song S. Gastricadenocarcinoma. Nat Rev Dis Primers. 2017;3:17036. doi:10.1038/nrdp.2017.36
9. Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric cancer:epidemiology, risk factors, classification, genomic characteristicsand treatment strategies. Int J Mol Sci. 2020;21(11):4012. doi:10.3390/ijms21114012
10. Mizota Y, Yamamoto S. How long should we continue gastric cancerscreening? From an epidemiological point of view. Gastric Cancer.2019;22(3):456-462. doi:10.1007/s10120-018-0877-z
11. von Elm E, Altman DG, Egger M, et al. The strengthening the reportingof observational studies in epidemiology (STROBE) statement:guidelines for reporting observational studies. J Clin Epidemiol.2008;61(4):344-349. doi:10.1016/j.jclinepi.2007.11.008
12. Zhang W, Li Z, Akram MS, et al. Gastric cancer screening methods:a comparative study of two scoring methods. Cancer Manag Res.2021;13:5785-5791. doi:10.2147/CMAR.S308395
13. Sumiyama K. Past and current trends in endoscopic diagnosis for early-stage gastric cancer in Japan. Gastric Cancer. 2017;20(Suppl 1):20-7.doi: 10.1007/s10120-016-0659-4
14. Bartfeld S, Bayram T, van de Wetering M, et al. In vitro expansion ofhuman gastric epithelial stem cells and their responses to bacterialinfection. Gastroenterology. 2015;148(1):126-136.e6. doi:10.1053/j.gastro.2014.09.042
15. Shimada S, Sawada N, Ishiyama Y, et al. Impact of obesity on short-and long-term outcomes of laparoscopy assisted distal gastrectomy forgastric cancer. Surg Endosc. 2018;32(1):358-366. doi:10.1007/s00464-017-5684-9
16. Alkebsi L, Ideno Y, Lee JS, et al. Gastroduodenal ulcers and ABOblood group: the Japan Nurses&rsquo; Health Study (JNHS). J Epidemiol.2018;28(1):34-40. doi:10.2188/jea.JE20160204
17. Hohenberger P, Gretschel S. Gastric cancer. Lancet. 2003;362(9380):305-315. doi:10.1016/s0140-6736(03)13975-x
18. Wong MCS, Huang J, Chan PSF, et al. Global incidence and mortalityof gastric cancer, 1980-2018. JAMA Netw Open. 2021;4(7):e2118457.doi:10.1001/jamanetworkopen.2021.18457
19. Joharatnam-Hogan N, Shiu KK, Khan K. Challenges in the treatmentof gastric cancer in the older patient. Cancer Treat Rev. 2020;85:101980.doi:10.1016/j.ctrv.2020.101980
20. Wang Z, Liu L, Ji J, et al. ABO blood group system and gastric cancer: acase-control study and meta-analysis. Int J Mol Sci. 2012;13(10):13308-13321. Published 2012 Oct 17. doi:10.3390/ijms131013308
21. Yu H, Xu N, Li ZK, et al. Association of ABO Blood Groupsand Risk of Gastric Cancer. Scand J Surg. 2020;109(4):309-313.doi:10.1177/1457496919863886
22. Kato Y, Kitagawa T, Nakamura K, Sugano H. Changes inthe histologic types of gastric carcinoma in Japan. Cancer.1981;48(9):2084-2087. doi:10.1002/1097-0142(19811101)48:9&lt;2084::aid-cncr2820480928&gt;3.0.co;2-8
23. Dittmar Y, Rauchfuss F, G&ouml;tz M, Scheuerlein H, Jandt K, Settmacher U.Impact of clinical and pathohistological characteristics on the incidenceof recurrence and survival in elderly patients with gastric cancer. WorldJ Surg. 2012;36(2):338-345. doi:10.1007/s00268-011-1395-x
24. Choi JY, Ha TK, Kwon SJ. Clinicopathologic characteristics of gastriccancer patients according to the timing of the recurrence after curativesurgery. J Gastric Cancer. 2011;11(1):46-54. doi:10.5230/jgc.2011.11.1.46
25. Mansouri H, Zemni I, Achouri L, et al. Chemoradiotherapy orchemotherapy as adjuvant treatment for resected gastric cancer: shouldwe use selection criteria?. Rep Pract Oncol Radiother. 2021;26(2):266-280. doi:10.5603/RPOR.a2021.0040
26. Zhang XF, Huang CM, Lu HS, et al. Surgical treatment andprognosis of gastric cancer in 2,613 patients. World J Gastroenterol.2004;10(23):3405-3408. doi:10.3748/wjg.v10.i23.3405
27. Patel PR, Yao JC, Hess K, Schnirer I, Rashid A, Ajani JA. Effect oftiming of metastasis/disease recurrence and histologic differentiationon survival of patients with advanced gastric cancer. Cancer.2007;110(10):2186-2190. doi:10.1002/cncr.23046
28. Rohatgi PR, Yao JC, Hess K, et al. Outcome of gastric cancer patientsafter successful gastrectomy: influence of the type of recurrence andhistology on survival. Cancer. 2006;107(11):2576-2580. doi:10.1002/cncr.22317
29. Asoglu O, Karanlik H, Parlak M, et al. Metastatic lymph noderatio is an independent prognostic factor in gastric cancer.Hepatogastroenterology. 2009;56(91-92):908-913.
30. Siewert JR, B&ouml;ttcher K, Stein HJ, Roder JD. Relevant prognostic factorsin gastric cancer: ten-year results of the German gastric cancer study.Ann Surg. 1998;228(4):449-461. doi:10.1097/00000658-199810000-00002
Article available in :
Volume 1, Issue 2, 2023
Page : 36-40
https://doi.org/10.51271/JCHOR-0009
Article Information
Received : 02 May 2023
Accepted : 23 May 2023
Published : 29 May 2023
Corresponding Author :

Mustafa Büyükkör: Dr.Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

[email protected]
Citation : Büyükkör M, Tay F, Özakyol Harmancı A. Gastric cancer patient characteristics in a city in the Central Anatolian Region of Turkey: a single-center descriptive study. J Curr Hematol Oncol Res. 2023;1(2):36-40.

Read: 194
Cited: 0
Download : 287
_Footer